Breaking News

Capsugel Expands Capabilities

To offer more clinical trial services as well as high potency compounds

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Capsugel, which is now part of Lonza, has expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialized drug products utilizing liquid-filled hard capsule (LFHC) technology, at its Edinburgh facility in Scotland. The company is enhancing its micro-dosing services offering for early-phase cGMP manufacturing at its Edinburgh facility. It is combining its proprietary Xcelodose Precision Powder Micro-Dosing Systems with powder-in-capsule/pow...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters